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Summary In this investigation we demonstrate expression of myc oncoproteins in HOC-7 ovarian adenocar-
cinoma cells. The cells were exposed to differentiation inducing agents such as dimethyl sulfoxide (DMSO),
N,N-dimethylformamide (DMF), retinoic acid (RA) and transforming growth factor-Pl (TGF-P1). Myc
protein expression in treated cells was then compared with that in control cultures and in monoclonal HOC-7
sublines, which are characterised by distinct phenotypes. Cells exposed to DMSO and DMF became markedly
enlarged and flattened and developed cytoplasmic extensions. They looked similar to a subline, which revealed
a less malignant and more differentiated cell phenotype. All four inducers prolonged the cell doubling time and
reduced the saturation density to levels, normally found in the more differentiated subline. Furthermore, all
inducers except RA elevated extracellular fibronectin, which is characteristic for less malignant epithelial cell
phenotypes. All four agents inhibited myc oncoprotein expression reversibly (1% DMSO>0.5%
DMF>10 JM RA> lOng ml' TGF-P1) and in time-dependent manner. Down-regulation of myc protein
expression is, therefore, closely related to inducer-dependent growth reduction of HOC-7 cells and to the
development of a less malignant cell phenotype.
Artificially stimulated differentiation of tumour cell lines in
vitro frequently mimics normal cell maturation (Siracky et
al., 1985). Exposure of malignant cells to differentiation
inducing agents such as dimethyl sulfoxide (DMSO), N,N-
dimethylformamide (DMF), retinoic acid (RA) and trans-
forming growth factor-P1 (TGF-P1) can stimulate these cells
to develop a more benign phenotype. The synthetic inducers
DMSO and DMF cause conformational alterations of DNA-
chromatin complexes, thus initiating transcription of differ-
entiation-associated genes (Reboulleau & Shapiro, 1983) and
increase the phase transition temperature of phospholipid
membranes, thereby inducing membrane stabilisation and
reduction of membrane fluidity (Lyman et al., 1976). Trans-
forming growth factors-P, on the other hand, as well as
retinoids represent naturally occurring regulators of cell
growth and differentiation. They are thought to exert their
effects via interaction with specific cell surface or nuclear
receptors (Sporn & Roberts, 1983; Petkovich et al., 1987;
Massague, 1987).
Using the polyclonal human ovarian adenocarcinoma cell
line HOC-7 (Buick et al., 1985) we compared the effects of
these inducers on cell growth and cell morphology, and
demonstrated an inducer-dependent down-regulation of myc
oncoproteins, which was in contrast to a stimulated produc-
tion of fibronectin. The induced phenotypes were then com-
pared with those occurring spontaneously and specifically in
various monoclonal sublines, which have been originally
isolated from the untreated parental HOC-7 cell line (Grunt
et al., 1991a).
Ovarian adenocarcinomas have a distinctive pattern of
oncogene alterations, which is characterised by a relatively
high frequency of c-myc amplifications (Zhou et al., 1988;
Fukumoto et al., 1989; Sasano et al., 1990). The c-myc
oncogene encodes for a 62 kDa nuclear protein with DNA-
binding capacity (Alitalo et al., 1983). A good correlation
exists between the expression of c-myc and cell transforma-
tion. In small cell lung cancer, for instance, the amounts of
c-myc mRNA and protein correlate with the degree of malig-
nancy (Nau et al., 1985). And in neuroblastomas, N-myc
overexpression is indicative for a poor prognosis (Schwab,
1986). Locker and co-workers (1989) established a relation-
ship between histopathological tumour grade and c-myc
oncoprotein levels in primary breast cancer.
In this investigation we demonstrated the time-dependent
modulation of the expression of myc oncoproteins in HOC-7
cells in response to differentiation promoters. Our data
indicate that the decline of myc expression is closely related
to the inducer-dependent growth reduction and to the
development of a less malignant phenotype in HOC-7
ovarian cancer cells.
Materials and methods
Cell culture
The ovarian adenocarcinoma cell line HOC-7 (Buick et al.,
1985) was maintained (37°C, 5% CO2) in a-MEM (Gibco,
Karlsruhe, Germany) containing 10% heat inactivated fetal
calf serum (FCSHI; Gibco) (standard medium).
Monoclonal sublines derived from HOC-7 parental cells
were established by density gradient separation and limiting
dilution as described previously (Grunt et al., 1991a).
DMSO (Sigma, Deisenhofen, Germany) and DMF (Sigma)
were diluted directly with standard medium. ,-all-trans RA
(Sigma), however, was dissolved in 95% ethanol and stored
under light protection at - 70°C. TGF-PI from human
platelets (R&D-Systems, Minneapolis, MN, USA) was
prepared in 4 mM HCI containing 1 mg ml-' bovine serum
albumin (Behring, Marburg, Germany). Both stock solutions
were diluted 1:1000 with standard medium containing the
cells. The cultures were exposed for various times to 1.0%
DMSO (v/v), 0.5% DMF (v/v), 10OJM RA and lOngml-'
TGF-p13.
Five thousand cells suspended in 5ml standard medium
with or without inducers were plated in triplicates in T25
tissue culture flasks (Falcon, Heidelberg, Germany). Media
were changed every 4 d. The cell numbers were determined
on 3, 4, 6, 7, 8, 10 and 14 d, and the doubling times were
calculated between days 3 and 7.
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Immunofluorescence and immunocytochemistry
Acetone-fixed cells (10 min, 4°C) were exposed (1 h, 4°C) to
rabbit anti-human fibronectin (1:300; Dakopatts, Glostrup,
Denmark) or to rabbit anti-human c-myc (1:300; obtained
from Dr A.R. Shatzman, Smith Kline Beckman Corp.,
Philadelphia, PA, USA). After rinsing with ice-cold phos-
phate-buffered saline (PBS; Gibco) the cells were labelled
(1 h, 4°C) with FITC-conjugated goat anti-rabbit IgG (1:50;
Jackson Immunoresearch Lab., West Grove, PA, USA) or
with peroxidase-conjugated goat anti-rabbit IgG (1:100,
Dakopatts) and evaluated in a Leitz Fluovert microscope.
Western blotting
For the detection of myc oncoproteins the cells were grown
for 4d in standard medium and then treated for various times
a
with the inducers. Subsequently they were trypsinised and
washed three times with a-MEM, adjusted to 2.5 x 104 per ftl
and lysed with the following buffer: 1.7% SDS, tris buffered
saline, pH 6.8. Released DNA was sheared by repeated nee-
dle passages (19, 21 and 23 gauge). The lysates were cleared
by centrifugation (3,000g, 15 min). To the supernatants
bromphenolblue/glycerine (final conc. 0.015%/6%), SDS
(final conc. 2%) and ,-mercaptoethanol (final conc. 5%)
were added and the samples were adjusted to the original
volume using lysis buffer. The protein content was deter-
mined by Lowry-assay (Freshney, 1987) and 40fil of each
sample (representing 1 x 106 cells or 600 Lg protein) were
separated on 10% SDS-PAGE according to the method of
Laemmli (1970).
Electrotransfer (Trans-Blot Cell, Bio-Rad Lab., CA, USA)
of the proteins onto nitrocellulose membranes (Hybond-C,
Amersham, UK) (Towbin et al., 1979) was followed by
b c
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Figure 1 Morphology of HOC-7 cell cultures. Phase-contrast micrographs. x 150. Polyclonal cultures a-e were grown for 4 d in
standard medium a containing 1% DMSO b, 0.5% DMF c, 10JiM RA d or 10 ngml-' TGF-PI e. Monoclonal HOC-7 sublines NI
f and D3 g were cultured for 4 d in standard medium.MYC EXPRESSION IN HOC-7 OVARIAN CANCER CELLS 95
Table I Growth properties of HOC-7 cells
Doubling Saturation
timea densit/A
(h) (% ofControl)
HOC-7 Control 23.6 1OOC
Inducers
1% DMSO 45.3 12
0.5% DMF 52.2 9
101gMRA 31.2 59
10 ngml-' TGF-Pf1 29.4 65
NI Subline 23.6 130
D3 Subline 45.4 45
aCalculated between days 3 and 7. bAfter 14 d of cultivation.
C2.76 x 105 cells cm-2
a
c
saturation for 2 h in 10% non-fat dry milk in PBS containing
0.1% Tween 20. The membranes were then incubated (12 h,
4°C) with peptide-induced, affinity-purified sheep polyclonal
anti-myc (1:300, Cambridge Research Biochemicals, Cam-
bridge, UK) followed by rabbit polyclonal anti-actin (6 h,
4°C, 1:5,000; Chemicon, Temecula, CA, USA). After
washing, the blot membranes were exposed (12 h, 4°C) to
biotinylated second antibodies against sheep and rabbit
immunoglobulins (1:30,000; Chemicon) and to 12511
Streptavidin (2 h, 4°C, 90 nCi ml ', specific activity
20-40 j.CiItg- ; Amersham, UK). The protein bands were
detected by autoradiography on X-ray film (Kodak,
Rochester, NY, USA). Quantitative evaluation was per-
formed with an Elscript 400 densitometer (Hirschmann,
Munich, Germany). The concentrations of myc oncoproteins
b
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Figure 2 Immunofluorescent detection of fibronectin in HOC-7 cell cultures. x 380. Polyclonal cultures were grown for 7 d in
standard medium a containing 1% DMSO b, 0.5% DMF c, 10fM RA d or 10 ngml-' TGF-pi e. Monoclonal HOC-7 sublines NI
f and D3 g were cultured for 7 d in standard medium.96 C. SOMAY et al.
were expressed relative to actin, which was used as internal
standard. The integrated area under the myc-specific
absorption-peak was compared to that under the correspon-
ding actin-peak. The myc/actin ratios determined in unt-
reated polyclonal cells (control)-ranging between 2.05 and
4.23-were then normalised to 100%, and the values
obtained in experimental cells were expressed in per cent of
control.
Results
Cell morphology andproliferation characteristics
Untreated HOC-7 cells were small and exhibited a polygonal
shape. However, during the first 3d of treatment with polar-
planar compounds like DMSO and DMF the cells became
gradually enlarged and flattened and developed cytoplasmic
extensions. This morphology remained then stable. Quali-
tatively similar, but markedly weaker effects were obtained
after exposure of the cells to RA and to TGF-PI (Figure 1).
All four inducers prolonged the cell doubling time and
reduced the saturation density in monolayer culture. Again,
the polar agents were more potent than RA and TGF-,13
(Table I). These alterations of cell growth and morphology
were found to be reversible. Six days of recultivation in
standard medium caused the cells to return to their original
morphology and growth rate.
Using limiting dilution we established several monoclonal
sublines derived from untreated HOC-7 cells and charac-
terised them with respect to morphology, growth rate and
saturation density. The HOC-7 subline NI, for instance,
represented cells, which looked like untreated parental cells,
whereas subline D3 exhibited a morphology and growth
pattern similar to that found in DMSO- and DMF-treated
cultures (Figure 1). Evaluation of the growth behaviour of
these sublines revealed that doubling time and saturation
density of NI lie in the range of untreated control cultures.
The growth parameters of D3 cells, however, were similar to
those obtained in inducer-exposed parental cells (Table I).
Expression offibronectin
Immunofluorescence was used to demonstrate production of
fibronectin in HOC-7 cells. Untreated monolayers revealed
finely distributed granular depositions (Figure 2a). DMSO-
and DMF-exposed cells, however, were characterised by
elevated staining in the cytoplasmic and extracellular com-
partment (Figure 2b-c). RA, on the other hand, had no
effects (Figure 2d), whereas TGF-P1 elevated the granular
Table II Semiquantitative determination of inducer-dependent myc
reduction in HOC-7 cells
myc/actin
(% ofControl)a
DMSO DMF RA TGF-P1
4d Control 100 100 100 100
10 mmn 53 n.d.b n.d. n.d.
30 min 43 n.d. n.d. n.d.
I h 35 48 99 99
2h 26 46 98 86
4 h 21 44 51 77
5d Control 100 100 100 100
I d 40 48 63 73
6 d Control 100 100 100 100
2 d 38 41 59 48
7 d Control 100 100 100 100
3 d 18 23 27 52
13 d Control 100 100 100 100
9 d 33 30 56 55
9 d + 6 d standard medium 71 93 87 79
aActin was used asinternal standard and the ratios between the myc-
and the actin-specific absorption peaks were calculated from
densitometer scans of autoradiographs obtained from Western blots
and expressed in percent ofcontrol. bNot determined.
fluorescence markedly (Figure 2e). NI cells (Figure 2f)
revealed a staining pattern, which was similar to that seen in
untreated control cultures. Cells from subline D3, however,
were found to produce large amounts of fibronectin (Figure
2g).
Expression ofmyc oncoproteins
SDS-PAGE and immunoblotting were used to demonstrate
the time-course of the inducer-dependent modulation of myc
oncoprotein expression (Figure 3). The autoradiographs were
evaluated densitometrically and the ratios of the areas under
the myc and actin peaks were calculated for each lane. Actin
was used as internal standard as its expression has been
found to remain unaffected by the treatment. The polar
agents caused a rapid reduction of myc. Within 1 h of
exposure to DMSO and DMF the myc/actin-ratios dropped
down from 100% in the control lanes to 35% and 48%
respectively (Table II). In contrast, RA and TGF-,1I did not
reduce myc protein markedly until 4 h of incubation (Table
II). The reduction of myc expression-occurring much ear-
lier than cellular flattening-tended to proceed in each
experimental group and reached lowest levels after 2 d (TGF-
PI) or 3 d (DMSO, DMF, RA) of exposure. At this time the
Mr
x10-3
71 -
45 -
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<4b
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Figure 3 Western blot analysis of myc oncoprotein expression in HOC-7 cells, which were grown for 4 d in standard medium and
then exposed for various times to I% DMSO. a: myc-band (62 kDa), b: actin-band (43 kDa). Lane 2: 10min; lane 3: 30min; lane
4: 1 h; lane 5: 2 h; lane 6: 4 h; lane 8: 1 d; lane 10: 2 d; lane 12: 3 d; lane 14: 9d; lane 15: 9 d + 6 d return to standard medium; lane
16 4 d control labelled for myc only; lane 17: 4 d control labelled for actin only; lanes 1, 7, 9, 11 and 13 represent untreated
controls after 4 d, 5 d, 6 d, 7 d and 13 d of culture.MYC EXPRESSION IN HOC-7 OVARIAN CANCER CELLS 97
morphological alterations are completed. DMSO, DMF and
RA depressed myc expression to 18, 23 and 27% respectively,
whereas TGF-P1 reduced myc to 48% only (Table II). Con-
tinuous treatment of the cells for 9 d followed by additional
6 d of cultivation in the absence of inducers proved that the
myc protein reduction is partially reversible (Table II).
Immunocytochemical staining indicated that there was no
marked cell-to-cell variation in the intensity of the inducer-
dependent inhibition of myc expression. Figure 4a, for in-
stance, demonstrates strong granular staining in the nuclei of
untreated control cells. However, exposure of the cells to the
inducers caused homogenous reduction of the nuclear stain-
ing pattern in almost all cells (Figure 4b).
The myc/actin-ratios obtained form densitometer evalua-
tions of Western blots, which were derived from untreated
parental HOC-7 cells and from monoclonal sublines
indicated slightly increased amounts of myc protein in the
NI-clone (1.2-fold), but reduced levels in D3 cells (0.8-
fold-Table III).
Discussion
In this investigation we compared the effects of the
differentiation-inducing agents DMSO, DMF, RA and TGF-
P1 on HOC-7 ovarian adenocarcinoma cells. Reversible
inducer-dependent cell enlargement and flattening and the
a
b
Figure 4 Immunocytochemical detection of c-myc oncoprotein
in HOC-7 cell cultures. Hemotoxylin counterstaining. x 380.
Polyclonal cultures were grown for 7 d in standard medium a or
in medium containing 10 j1M RA b.
TableIII SemiquantitativedeterminationofmycexpressioninHOC-7
parental cells (control) and derived monoclonal sublines grown for4 d
in standard medium
myc/actin
(% ofControl)a
HOC-7 100
N1 124
D3 77
aActin was used as internal standard and the ratios between themyc-
and the actin-specific absorption peaks were calculated from
densitometer scans of autoradiographs obtained from Western blots
and expressed in percent ofcontrol.
development of cytoplasmic extensions was accompanied by
elevated deposition of the extracellular matrix glycoprotein
fibronectin. Monolayer growth was markedly reduced and
the expression of myc oncoproteins was reversibly inhibited
in a time-dependent manner. Comparative analysis of the
cellular responses induced by the four inducers revealed that
the polar-planar agents DMSO and DMF exerted strong
effects on cell phenotype, proliferation and myc expression.
TGF-Pj1 and especially RA acted primarily as growth
inhibitors without inducing marked phenotypic alterations.
Interestingly, the two cell phenotypes corresponding either to
treated or to untreated cells (including all parameters tested)
could be observed separately and constantly in distinct
monoclonal HOC-7 sublines that have not been exposed to
inducers. The D3 subline, for instance, resembled inducer-
treated cells, whereas NI cells revealed a phenotype, which
was similar to that found in untreated HOC-7 cells. From
these findings we conclude that the polar agents more
efficiently than RA and TGF-,1I promoted cell processes,
which normally occur only in a minority of cells yielding a
more benign phenotype. Development of this phenotype was
recently found to be associated with elevated production of
cytokeratin and of desmosomal proteins (Grunt et al.,
1991b). Similar inducer-dependent responses have previously
been found in various other cell lines (Chakrabarty et al.,
1987; Hoosein et al., 1988) and have been attributed to
stimulated differentiation in these cells. Furthermore, the
significance of cytoskeleton expression and extracellular mat-
rix formation for cell maturation and gene regulation has
been well documented (Ruoslahti et al., 1981; De Petro et al.,
1983; Ben Ze'ev, 1989). However, the agents used in the
present study did not induce terminal differentiation of
HOC-7 cells as demonstrated by the gradual reappearance of
their original morphology and antigen pattern after returning
the cells to standard medium and regrowing them for 6 d.
Immunocytochemical staining of the cultures revealed that
the penetrance of the inhibitory effects of the agents on myc
oncoprotein expression might be equal in every single cell.
Thus, there seems to be no marked cell-to-cell variation in
the response of the cultures to these agents. This was seen
even in the monoclonal sublines: if NI cells were exposed to
DMSO or DMF, they developed a phenotype, which was
similar to that seen in treated polyclonal parental popula-
tions and in 'spontaneously differentiated' sublines (Grunt et
al., 1991b).
Genetic alterations in control sequences regulating the ex-
pression of myc-oncogenes are frequently seen in malignancy
(Dani et al., 1985; Knight et al., 1985). We and other inves-
tigators (Birnie, 1988; Mulder & Brattain, 1988; Darling et
al., 1989) demonstrated that the aberrant high production of
the corresponding proteins is down-regulated to normal
levels, if the cells are exposed to differentiation promoters.
The analysis of the effects of each of these inducers on
HOC-7 cell growth and phenotypes indicated that reduction
of myc expression is closely related to inhibition of cell
growth and to the development of a less malignant
phenotype. Persistent inducer-dependent down-regulation of
myc proteins may subsequently trigger cell maturation pro-
cesses in these cells.98 C. SOMAY et al.
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